BBOT
Price
$11.98
Change
-$0.23 (-1.88%)
Updated
Oct 8, 04:59 PM (EDT)
Capitalization
966.99M
56 days until earnings call
VTGN
Price
$4.01
Change
+$0.05 (+1.26%)
Updated
Oct 8, 04:59 PM (EDT)
Capitalization
121.49M
Interact to see
Advertisement

BBOT vs VTGN

Header iconBBOT vs VTGN Comparison
Open Charts BBOT vs VTGNBanner chart's image
BridgeBio Oncology Therapeutics
Price$11.98
Change-$0.23 (-1.88%)
Volume$5.02K
Capitalization966.99M
VistaGen Therapeutics
Price$4.01
Change+$0.05 (+1.26%)
Volume$1.41K
Capitalization121.49M
BBOT vs VTGN Comparison Chart in %
BBOT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VTGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BBOT vs. VTGN commentary
Oct 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BBOT is a StrongBuy and VTGN is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 09, 2025
Stock price -- (BBOT: $12.21 vs. VTGN: $3.96)
Brand notoriety: BBOT and VTGN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BBOT: 56% vs. VTGN: 154%
Market capitalization -- BBOT: $966.99M vs. VTGN: $121.49M
BBOT [@Biotechnology] is valued at $966.99M. VTGN’s [@Biotechnology] market capitalization is $121.49M. The market cap for tickers in the [@Biotechnology] industry ranges from $105.19B to $0. The average market capitalization across the [@Biotechnology] industry is $2.05B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BBOT’s FA Score shows that 1 FA rating(s) are green whileVTGN’s FA Score has 0 green FA rating(s).

  • BBOT’s FA Score: 1 green, 4 red.
  • VTGN’s FA Score: 0 green, 5 red.
According to our system of comparison, both BBOT and VTGN are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BBOT’s TA Score shows that 6 TA indicator(s) are bullish while VTGN’s TA Score has 6 bullish TA indicator(s).

  • BBOT’s TA Score: 6 bullish, 3 bearish.
  • VTGN’s TA Score: 6 bullish, 3 bearish.
According to our system of comparison, VTGN is a better buy in the short-term than BBOT.

Price Growth

BBOT (@Biotechnology) experienced а +5.44% price change this week, while VTGN (@Biotechnology) price change was +11.55% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +9.11%. For the same industry, the average monthly price growth was +19.03%, and the average quarterly price growth was +87.04%.

Reported Earning Dates

BBOT is expected to report earnings on Dec 03, 2025.

Industries' Descriptions

@Biotechnology (+9.11% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BBOT($967M) has a higher market cap than VTGN($121M). VTGN YTD gains are higher at: 34.237 vs. BBOT (16.286). VTGN has higher annual earnings (EBITDA): -58.99M vs. BBOT (-94.43M). BBOT has more cash in the bank: 131M vs. VTGN (63.2M). VTGN has less debt than BBOT: VTGN (2.36M) vs BBOT (2.83M). VTGN has higher revenues than BBOT: VTGN (646K) vs BBOT (0).
BBOTVTGNBBOT / VTGN
Capitalization967M121M799%
EBITDA-94.43M-58.99M160%
Gain YTD16.28634.23748%
P/E RatioN/AN/A-
Revenue0646K-
Total Cash131M63.2M207%
Total Debt2.83M2.36M120%
FUNDAMENTALS RATINGS
VTGN: Fundamental Ratings
VTGN
OUTLOOK RATING
1..100
5
VALUATION
overvalued / fair valued / undervalued
1..100
47
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
38
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BBOTVTGN
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
7%
Bearish Trend 2 days ago
89%
Momentum
ODDS (%)
Bullish Trend 3 days ago
25%
Bullish Trend 2 days ago
84%
MACD
ODDS (%)
Bullish Trend 3 days ago
38%
Bullish Trend 2 days ago
81%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
29%
Bullish Trend 2 days ago
81%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
27%
Bullish Trend 2 days ago
81%
Advances
ODDS (%)
Bullish Trend 7 days ago
35%
Bullish Trend 2 days ago
80%
Declines
ODDS (%)
Bearish Trend 10 days ago
26%
Bearish Trend 23 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
14%
Bullish Trend 2 days ago
87%
Aroon
ODDS (%)
Bullish Trend 2 days ago
14%
Bullish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
BBOT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VTGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PTCHF1.90N/A
N/A
PureTech Health PLC
SNPHF11.45N/A
N/A
Santen Pharmaceutical Co., Ltd.
JXHLY12.87N/A
N/A
Eneos Holdings Inc.
OILCF3.60N/A
N/A
Permex Petroleum Corporation
TSGZF0.13-0.01
-5.34%
TriStar Gold, Inc.

BBOT and

Correlation & Price change

A.I.dvisor tells us that BBOT and COCP have been poorly correlated (+25% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BBOT and COCP's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BBOT
1D Price
Change %
BBOT100%
-2.55%
COCP - BBOT
25%
Poorly correlated
-0.82%
VKTX - BBOT
23%
Poorly correlated
-2.31%
PRTC - BBOT
22%
Poorly correlated
-3.29%
RAPP - BBOT
22%
Poorly correlated
-4.69%
VTGN - BBOT
21%
Poorly correlated
+1.80%
More

VTGN and

Correlation & Price change

A.I.dvisor indicates that over the last year, VTGN has been loosely correlated with COGT. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if VTGN jumps, then COGT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VTGN
1D Price
Change %
VTGN100%
+1.80%
COGT - VTGN
42%
Loosely correlated
-2.89%
SYRE - VTGN
41%
Loosely correlated
-3.90%
IMNM - VTGN
40%
Loosely correlated
-4.09%
SRRK - VTGN
40%
Loosely correlated
-0.75%
IPSC - VTGN
39%
Loosely correlated
+0.59%
More